PolTREG S.A. (PTG) - Total Liabilities
Based on the latest financial reports, PolTREG S.A. (PTG) has total liabilities worth zł30.71 Million PLN (≈ $8.45 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
PolTREG S.A. - Total Liabilities Trend (2018–2024)
This chart illustrates how PolTREG S.A.'s total liabilities have evolved over time, based on quarterly financial data. See PTG working capital ratio to evaluate short-term liquidity relative to the company's equity base.
PolTREG S.A. Competitors by Total Liabilities
The table below lists competitors of PolTREG S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
EDGE TOTAL INTELLIGENCE
F:Q5I
|
Germany | €5.40 Million |
|
Giyani Metals Corp
V:EMM
|
Canada | CA$40.22 Million |
|
Marti Otel Isletmeleri AS
IS:MARTI
|
Turkey | TL9.74 Billion |
|
Daesung Eltec Co. Ltd
KQ:025440
|
Korea | ₩292.76 Billion |
|
Choo Bee Metal Industries Bhd
KLSE:5797
|
Malaysia | RM10.62 Million |
|
Biotoxtech Co. Ltd
KQ:086040
|
Korea | ₩98.39 Billion |
|
Times Guaranty Limited
NSE:TIMESGTY
|
India | Rs1.67 Million |
|
Kalyani Forge Limited
NSE:KALYANIFRG
|
India | Rs1.67 Billion |
Liability Composition Analysis (2018–2024)
This chart breaks down PolTREG S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PTG company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.62 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PolTREG S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PolTREG S.A. (2018–2024)
The table below shows the annual total liabilities of PolTREG S.A. from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | zł33.15 Million ≈ $9.12 Million |
-16.26% |
| 2023-12-31 | zł39.58 Million ≈ $10.89 Million |
+77.77% |
| 2022-12-31 | zł22.27 Million ≈ $6.13 Million |
+263.93% |
| 2021-12-31 | zł6.12 Million ≈ $1.68 Million |
+79.41% |
| 2020-12-31 | zł3.41 Million ≈ $938.48K |
-50.23% |
| 2019-12-31 | zł6.85 Million ≈ $1.89 Million |
-29.37% |
| 2018-12-31 | zł9.70 Million ≈ $2.67 Million |
-- |
About PolTREG S.A.
Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.